Safety profile of antidepressant for Japanese adults with major depressive disorder: A systematic review and network meta-analysis
Psychiatry Clin Neurosci
.
2024 Feb;78(2):142-144.
doi: 10.1111/pcn.13622.
Epub 2023 Dec 10.
Authors
Taro Kishi
1
,
Toshikazu Ikuta
2
,
Kenji Sakuma
1
,
Masakazu Hatano
3
,
Yuki Matsuda
4
,
Satoru Esumi
5
,
Nobumi Miyake
6
,
Itaru Miura
7
,
Masaki Kato
8
,
Nakao Iwata
1
Affiliations
1
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
2
Department of Communication Sciences and Disorders, School of Applied Sciences, University of Mississippi, University, Mississippi, USA.
3
Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan.
4
Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan.
5
Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan.
6
Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Japan.
7
Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan.
8
Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
PMID:
37984427
DOI:
10.1111/pcn.13622
No abstract available
Publication types
Meta-Analysis
Systematic Review
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adult
Antidepressive Agents / adverse effects
Depressive Disorder, Major* / drug therapy
Humans
Japan
Network Meta-Analysis
Substances
Antidepressive Agents
Grants and funding
23K06998/Grant-in-Aid for Scientific Research (C)